Clinical Trial Update: TRIal evalUating the Menstrual and Ovarian Function of Young Breast Cancer Patients Treated With a cycloPHosphamide-free Regimen [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing menstrual and ovarian function in young breast cancer patients treated with a cyclophosphamide-free regimen has been withdraw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• cyclophosphamide-free regimen (study regimen) (cyclophosphamide-free regimen)

Snippet

Sponsor: Jules Bordet Institute | Conditions: Breast Cancer | Phase 2 | Status: WITHDRAWN